LENZ Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
LENZ Therapeutics Total Assets Growth & History (LENZ)
LENZ Therapeutics's total assets was $305.9M for fiscal 2025.
View full LENZ Therapeutics company overviewLENZ Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $305.9M | $90.6M | +42.07% |
| 2024 | 2024-12-31 | $215.3M | $144.9M | +205.93% |
| 2023 | 2023-12-31 | $70.4M | −$251.5M | −78.14% |
| 2022 | 2022-12-31 | $321.9M | −$80.1M | −19.92% |
| 2021 | 2021-12-31 | $402.0M | $379.4M | +1681.54% |
| 2020 | 2020-12-31 | $22.6M | — | — |
LENZ Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $236.6M | $19.3M | +8.86% |
| Q1 2026 | 2026-03-31 | $272.5M | $71.3M | +35.42% |
| Q4 2025 | 2025-12-31 | $305.9M | $90.6M | +42.07% |
| Q3 2025 | 2025-09-30 | $210.7M | −$13.3M | −5.94% |
| Q2 2025 | 2025-06-30 | $217.3M | $14.7M | +7.25% |
| Q1 2025 | 2025-03-31 | $201.3M | −$16.1M | −7.39% |
| Q4 2024 | 2024-12-31 | $215.3M | $144.9M | +205.93% |
| Q3 2024 | 2024-09-30 | $224.0M | −$42.2M | −15.86% |
| Q2 2024 | 2024-06-30 | $202.6M | −$84.4M | −29.40% |
| Q1 2024 | 2024-03-31 | $217.3M | −$92.7M | −29.90% |
| Q4 2023 | 2023-12-31 | $70.4M | −$251.5M | −78.14% |
| Q3 2023 | 2023-09-30 | $266.2M | −$68.6M | −20.49% |
| Q2 2023 | 2023-06-30 | $287.0M | −$66.7M | −18.87% |
| Q1 2023 | 2023-03-31 | $310.0M | −$68.6M | −18.12% |
| Q4 2022 | 2022-12-31 | $321.9M | −$80.1M | −19.92% |
| Q3 2022 | 2022-09-30 | $334.8M | −$81.3M | −19.54% |
| Q2 2022 | 2022-06-30 | $353.8M | −$33.3M | −8.61% |
| Q1 2022 | 2022-03-31 | $378.6M | — | — |
| Q4 2021 | 2021-12-31 | $402.0M | $379.4M | +1681.54% |
| Q3 2021 | 2021-09-30 | $416.2M | — | — |
| Q2 2021 | 2021-06-30 | $387.1M | — | — |
| Q4 2020 | 2020-12-31 | $22.6M | — | — |
LENZ Therapeutics total assets trends
Over the last five fiscal years, LENZ Therapeutics's total assets increased from $22.6M to $305.9M, a change of $283.3M. The latest reported quarter, Q2 2026, shows $236.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LENZ Therapeutics source filings ↗